Evaluation of Infections in Intensive Care Units: A Multicentre Point-Prevalence Study

dc.contributor.authorArac, Esef
dc.contributor.authorKaya, Safak
dc.contributor.authorParlak, Emine
dc.contributor.authorBuyuktuna, Seyit Ali
dc.contributor.authorBaran, Ali Irian
dc.contributor.authorAkgul, Fethiye
dc.contributor.authorGokler, Mehmet Enes
dc.date.accessioned2024-04-24T17:27:54Z
dc.date.available2024-04-24T17:27:54Z
dc.date.issued2019
dc.departmentDicle Üniversitesien_US
dc.description.abstractInfection control is a top priority for hospitals, especially in intensive care units (ICU). In intensive care units, prevalence of infection is estimated to be 30% worldwide, which is a major cause of morbidity and mortality. Many factors are known to increase the risk of infection in ICU patients. Since each of these may lead to different infections, it is important to recognize and identify predisposing factors for early diagnosis and treatment. The regional health care-associated infections (HCAI) prevalence and distribution of risk factors are important strategies in infection control. In this regard, the aim of this point prevalence study was to obtain data related to infections, the prevalence of HCAI among these infections, the epidemiology, agents and antibiotics used among adult ICU patients in the university hospitals, training and research hospitals and public hospitals located in eight of the cities of our region. In the light of these data, we aimed to review and emphasize the guidelines on HCAI prevention. The study included adult ICU patients followed up in nine hospitals in the Eastern and South-eastern Anatolia Regions of eight different cities (Sivas, Erzurum, Mardin, Batman, Diyarbakir Elazig, Van, Adiyaman) in Turkey. Of the hospitals six were university hospitals, one was training and research hospital, and two were public hospitals. The number of beds ranged from 358 to 1418. A specific day was determined on which the researchers concurrently carried out a prospective surveillance in all adult intensive care unit patients. The researchers collected data and recorded the demographic characteristics (age, gender), underlying diseases, length of hospital stay, presence of invasive intervention (urinary catheter, central venous catheter, external ventricular drainage, mechanical ventilator, presence of risk factors such as burn, trauma and surgery, number of infection cases, type of infection (hospital-acquired, community-acquired), type of microorganisms and whether polymicrobial or monomicrobial, which antibiotics were administered, and duration of antibiotic treatment. Our study assessed data of 429 inpatients in the adult ICU of nine hospitals in eight different cities. There were a total of 881 intensive care beds in these hospitals, and 740 (84%) beds were occupied. Of the study group 49.7% was male with a mean age (min-max) of 64.08 +/- 18.78 (2-97) years. The point prevalence of HCAI was 21.7% (n= 93). Of the patients who were followed-up 182 (42.4%) presented infections. Of these infections, 21.4% were diagnosed as community-acquired pneumonia, 18.6% were ventilator-associated pneumonia (VAP), 16.3% were community-acquired urinary tract infection (UTI), and 16.3% were bloodstream infection. In addition, the most commonly administered antibiotics in the study group were piperacillin/tazobactam, carbapenem, quinolone and ceftriaxone, respectively. The most common types of HCAI were community-acquired pneumonia (10.7%), ventilator-associated pneumonia (8.9%) and bloodstream infections (8.2%). The mean length of hospital stay was 32.05 +/- 66.85 (1-459) days and the mean duration of antibiotic therapy in patients with HCAls was 7.76 +/- 7.11 (1-41) days. The most widely accepted method to handle infection is to carry out active, prospective and patient-based surveillance studies on a regular basis, and to take control measures and arrange appropriate treatment in the light of the data obtained. We attribute the high prevalence of HCAI in our region to lack of personnel, lack of materials, inappropriate use of antibiotics, insufficiency of physical conditions, and little support for infection control committees. In conclusion, we emphasize that it is of importance to work closely with the hospital administration to take measures and that necessary assistance is provided.en_US
dc.identifier.doi10.5578/mb.68665
dc.identifier.endpage373en_US
dc.identifier.issn0374-9096
dc.identifier.issue4en_US
dc.identifier.pmid31709934
dc.identifier.scopus2-s2.0-85074741685
dc.identifier.scopusqualityQ3
dc.identifier.startpage364en_US
dc.identifier.trdizinid377126
dc.identifier.urihttps://doi.org/10.5578/mb.68665
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/377126
dc.identifier.urihttps://hdl.handle.net/11468/20244
dc.identifier.volume53en_US
dc.identifier.wosWOS:000490256400002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isotren_US
dc.publisherAnkara Microbiology Socen_US
dc.relation.ispartofMikrobiyoloji Bulteni
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIntensive Care Uniten_US
dc.subjectInfectionsen_US
dc.subjectPoint-Prevalenceen_US
dc.titleEvaluation of Infections in Intensive Care Units: A Multicentre Point-Prevalence Studyen_US
dc.titleEvaluation of Infections in Intensive Care Units: A Multicentre Point-Prevalence Study
dc.typeArticleen_US

Dosyalar